Cargando…
Challenging Scenarios and Debated Indications for Laparoscopic Liver Resections for Hepatocellular Carcinoma
SIMPLE SUMMARY: Minimally invasive liver resections are nowadays performed worldwide for both benign and malignant lesions. Good short-term and safe long-term outcomes have been reported. Despite this growing implementation of the technique, challenging scenarios and debated indications still exist....
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001345/ https://www.ncbi.nlm.nih.gov/pubmed/36900284 http://dx.doi.org/10.3390/cancers15051493 |
_version_ | 1784904113915428864 |
---|---|
author | Berardi, Giammauro Muttillo, Edoardo Maria Colasanti, Marco Mariano, Germano Meniconi, Roberto Luca Ferretti, Stefano Guglielmo, Nicola Angrisani, Marco Lucarini, Alessio Garofalo, Eleonora Chiappori, Davide Di Cesare, Ludovica Vallati, Damiano Mercantini, Paolo Ettorre, Giuseppe Maria |
author_facet | Berardi, Giammauro Muttillo, Edoardo Maria Colasanti, Marco Mariano, Germano Meniconi, Roberto Luca Ferretti, Stefano Guglielmo, Nicola Angrisani, Marco Lucarini, Alessio Garofalo, Eleonora Chiappori, Davide Di Cesare, Ludovica Vallati, Damiano Mercantini, Paolo Ettorre, Giuseppe Maria |
author_sort | Berardi, Giammauro |
collection | PubMed |
description | SIMPLE SUMMARY: Minimally invasive liver resections are nowadays performed worldwide for both benign and malignant lesions. Good short-term and safe long-term outcomes have been reported. Despite this growing implementation of the technique, challenging scenarios and debated indications still exist. There is currently a lack of high-quality evidence regarding minimally invasive liver resections in portal hypertension, advanced cirrhosis, lesions in the posterosuperior segments and large and recurrent tumors. ABSTRACT: Laparoscopic liver resections (LLRs) have been increasingly adopted for the treatment of hepatocellular carcinoma (HCC), with safe short- and long-term outcomes reported worldwide. Despite this, lesions in the posterosuperior segments, large and recurrent tumors, portal hypertension, and advanced cirrhosis currently represent challenging scenarios in which the safety and efficacy of the laparoscopic approach are still controversial. In this systematic review, we pooled the available evidence on the short-term outcomes of LLRs for HCC in challenging clinical scenarios. All randomized and non-randomized studies reporting LLRs for HCC in the above-mentioned settings were included. The literature search was run in the Scopus, WoS, and Pubmed databases. Case reports, reviews, meta-analyses, studies including fewer than 10 patients, non-English language studies, and studies analyzing histology other than HCC were excluded. From 566 articles, 36 studies dated between 2006 and 2022 fulfilled the selection criteria and were included in the analysis. A total of 1859 patients were included, of whom 156 had advanced cirrhosis, 194 had portal hypertension, 436 had large HCCs, 477 had lesions located in the posterosuperior segments, and 596 had recurrent HCCs. Overall, the conversion rate ranged between 4.6% and 15.5%. Mortality and morbidity ranged between 0.0% and 5.1%, and 18.6% and 34.6%, respectively. Full results according to subgroups are described in the study. Advanced cirrhosis and portal hypertension, large and recurrent tumors, and lesions located in the posterosuperior segments are challenging clinical scenarios that should be carefully approached by laparoscopy. Safe short-term outcomes can be achieved provided experienced surgeons and high-volume centers. |
format | Online Article Text |
id | pubmed-10001345 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100013452023-03-11 Challenging Scenarios and Debated Indications for Laparoscopic Liver Resections for Hepatocellular Carcinoma Berardi, Giammauro Muttillo, Edoardo Maria Colasanti, Marco Mariano, Germano Meniconi, Roberto Luca Ferretti, Stefano Guglielmo, Nicola Angrisani, Marco Lucarini, Alessio Garofalo, Eleonora Chiappori, Davide Di Cesare, Ludovica Vallati, Damiano Mercantini, Paolo Ettorre, Giuseppe Maria Cancers (Basel) Systematic Review SIMPLE SUMMARY: Minimally invasive liver resections are nowadays performed worldwide for both benign and malignant lesions. Good short-term and safe long-term outcomes have been reported. Despite this growing implementation of the technique, challenging scenarios and debated indications still exist. There is currently a lack of high-quality evidence regarding minimally invasive liver resections in portal hypertension, advanced cirrhosis, lesions in the posterosuperior segments and large and recurrent tumors. ABSTRACT: Laparoscopic liver resections (LLRs) have been increasingly adopted for the treatment of hepatocellular carcinoma (HCC), with safe short- and long-term outcomes reported worldwide. Despite this, lesions in the posterosuperior segments, large and recurrent tumors, portal hypertension, and advanced cirrhosis currently represent challenging scenarios in which the safety and efficacy of the laparoscopic approach are still controversial. In this systematic review, we pooled the available evidence on the short-term outcomes of LLRs for HCC in challenging clinical scenarios. All randomized and non-randomized studies reporting LLRs for HCC in the above-mentioned settings were included. The literature search was run in the Scopus, WoS, and Pubmed databases. Case reports, reviews, meta-analyses, studies including fewer than 10 patients, non-English language studies, and studies analyzing histology other than HCC were excluded. From 566 articles, 36 studies dated between 2006 and 2022 fulfilled the selection criteria and were included in the analysis. A total of 1859 patients were included, of whom 156 had advanced cirrhosis, 194 had portal hypertension, 436 had large HCCs, 477 had lesions located in the posterosuperior segments, and 596 had recurrent HCCs. Overall, the conversion rate ranged between 4.6% and 15.5%. Mortality and morbidity ranged between 0.0% and 5.1%, and 18.6% and 34.6%, respectively. Full results according to subgroups are described in the study. Advanced cirrhosis and portal hypertension, large and recurrent tumors, and lesions located in the posterosuperior segments are challenging clinical scenarios that should be carefully approached by laparoscopy. Safe short-term outcomes can be achieved provided experienced surgeons and high-volume centers. MDPI 2023-02-27 /pmc/articles/PMC10001345/ /pubmed/36900284 http://dx.doi.org/10.3390/cancers15051493 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Berardi, Giammauro Muttillo, Edoardo Maria Colasanti, Marco Mariano, Germano Meniconi, Roberto Luca Ferretti, Stefano Guglielmo, Nicola Angrisani, Marco Lucarini, Alessio Garofalo, Eleonora Chiappori, Davide Di Cesare, Ludovica Vallati, Damiano Mercantini, Paolo Ettorre, Giuseppe Maria Challenging Scenarios and Debated Indications for Laparoscopic Liver Resections for Hepatocellular Carcinoma |
title | Challenging Scenarios and Debated Indications for Laparoscopic Liver Resections for Hepatocellular Carcinoma |
title_full | Challenging Scenarios and Debated Indications for Laparoscopic Liver Resections for Hepatocellular Carcinoma |
title_fullStr | Challenging Scenarios and Debated Indications for Laparoscopic Liver Resections for Hepatocellular Carcinoma |
title_full_unstemmed | Challenging Scenarios and Debated Indications for Laparoscopic Liver Resections for Hepatocellular Carcinoma |
title_short | Challenging Scenarios and Debated Indications for Laparoscopic Liver Resections for Hepatocellular Carcinoma |
title_sort | challenging scenarios and debated indications for laparoscopic liver resections for hepatocellular carcinoma |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001345/ https://www.ncbi.nlm.nih.gov/pubmed/36900284 http://dx.doi.org/10.3390/cancers15051493 |
work_keys_str_mv | AT berardigiammauro challengingscenariosanddebatedindicationsforlaparoscopicliverresectionsforhepatocellularcarcinoma AT muttilloedoardomaria challengingscenariosanddebatedindicationsforlaparoscopicliverresectionsforhepatocellularcarcinoma AT colasantimarco challengingscenariosanddebatedindicationsforlaparoscopicliverresectionsforhepatocellularcarcinoma AT marianogermano challengingscenariosanddebatedindicationsforlaparoscopicliverresectionsforhepatocellularcarcinoma AT meniconirobertoluca challengingscenariosanddebatedindicationsforlaparoscopicliverresectionsforhepatocellularcarcinoma AT ferrettistefano challengingscenariosanddebatedindicationsforlaparoscopicliverresectionsforhepatocellularcarcinoma AT guglielmonicola challengingscenariosanddebatedindicationsforlaparoscopicliverresectionsforhepatocellularcarcinoma AT angrisanimarco challengingscenariosanddebatedindicationsforlaparoscopicliverresectionsforhepatocellularcarcinoma AT lucarinialessio challengingscenariosanddebatedindicationsforlaparoscopicliverresectionsforhepatocellularcarcinoma AT garofaloeleonora challengingscenariosanddebatedindicationsforlaparoscopicliverresectionsforhepatocellularcarcinoma AT chiapporidavide challengingscenariosanddebatedindicationsforlaparoscopicliverresectionsforhepatocellularcarcinoma AT dicesareludovica challengingscenariosanddebatedindicationsforlaparoscopicliverresectionsforhepatocellularcarcinoma AT vallatidamiano challengingscenariosanddebatedindicationsforlaparoscopicliverresectionsforhepatocellularcarcinoma AT mercantinipaolo challengingscenariosanddebatedindicationsforlaparoscopicliverresectionsforhepatocellularcarcinoma AT ettorregiuseppemaria challengingscenariosanddebatedindicationsforlaparoscopicliverresectionsforhepatocellularcarcinoma |